Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials

The identification of activated T-lymphocytes restricted to myelin-derived immunogenic peptides in multiple sclerosis (MS) and aquaporin-4 water channel in neuromyelitis optica (NMO) in the blood of patients opened the possibility for developing highly selective and disease-specific therapeutic appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Flórez-Grau, Georgina, Zubizarreta, Irati, Cabezón, Raquel, Villoslada, Pablo, Benitez-Ribas, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990597/
https://www.ncbi.nlm.nih.gov/pubmed/29904379
http://dx.doi.org/10.3389/fimmu.2018.01169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5990597/
https://www.ncbi.nlm.nih.gov/pubmed/29904379
http://dx.doi.org/10.3389/fimmu.2018.01169

Ejemplares similares